Amarin Corp Plc\Uk (AMRN) Latest Stock Analysis Report – Oct 16, 2026, 4:00 PM ET
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $11.32, -2.16% vs the prior close of $11.57.
- Volume 113.66K shares, 1.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
AMRN dips 2.2% to $11.32, a 52-week low. Closed at $11.32, -2.16% vs the prior close of $11.57. Day range $11.25–$11.57, opened at $11.50.
AMRN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — AMRN dips 2.2% to $11.32, a 52-week low
- Closed at $11.32, -2.16% vs the prior close of $11.57. Day range $11.25–$11.57, opened at $11.50.
- Volume was 113.66K shares, 1.7x its 50-day average of 68.17K.
- Price is -15.5% vs its 50-day average ($13.40) and -21.7% vs its 200-day average ($14.45).
- 52-week range $11.25–$20.90; today's close sits at 1% of that range, 45.8% below the 52-week high.
Oct 15, 2026 — AMRN dips 0.3% to $11.57
- Closed at $11.57, -0.34% vs the prior close of $11.61. Day range $11.56–$11.85, opened at $11.57.
- Volume was 54.40K shares, 0.8x its 50-day average of 67.68K.
- Price is -14.1% vs its 50-day average ($13.46) and -20.0% vs its 200-day average ($14.46).
- 52-week range $11.34–$20.90; today's close sits at 2% of that range, 44.6% below the 52-week high.
Oct 14, 2026 — AMRN ends flat (+0.3%) to $11.61
- Closed at $11.61, +0.26% vs the prior close of $11.58. Day range $11.40–$11.79, opened at $11.47.
- Volume was 51.00K shares, 0.7x its 50-day average of 68.20K.
- Price is -14.1% vs its 50-day average ($13.52) and -19.8% vs its 200-day average ($14.47).
- 52-week range $11.34–$20.90; today's close sits at 3% of that range, 44.4% below the 52-week high.
Oct 13, 2026 — AMRN rises 0.4% to $11.58
- Closed at $11.58, +0.43% vs the prior close of $11.53. Day range $11.34–$11.62, opened at $11.53.
- Volume was 102.40K shares, 1.5x its 50-day average of 67.83K.
- Price is -14.7% vs its 50-day average ($13.58) and -20.1% vs its 200-day average ($14.49).
- 52-week range $11.34–$20.90; today's close sits at 3% of that range, 44.6% below the 52-week high.
Oct 12, 2026 — AMRN slides 4.2% to $11.53, a 52-week low
- Closed at $11.53, -4.16% vs the prior close of $12.03. Day range $11.39–$11.93, opened at $11.93.
- Volume was 90.00K shares, 1.3x its 50-day average of 67.22K.
- Price is -15.4% vs its 50-day average ($13.63) and -20.5% vs its 200-day average ($14.50).
- 52-week range $11.39–$20.90; today's close sits at 1% of that range, 44.8% below the 52-week high.
Oct 9, 2026 — AMRN rises 0.3% to $12.03
- Closed at $12.03, +0.33% vs the prior close of $11.99. Day range $11.95–$12.20, opened at $11.99.
- Volume was 44.90K shares, 0.7x its 50-day average of 67.17K.
- Price is -12.1% vs its 50-day average ($13.68) and -17.1% vs its 200-day average ($14.51).
- 52-week range $11.83–$20.90; today's close sits at 2% of that range, 42.4% below the 52-week high.
Oct 8, 2026 — AMRN ends flat (-0.2%) to $11.99, a 52-week low, 8 down days in a row
- Closed at $11.99, -0.25% vs the prior close of $12.02. Day range $11.85–$12.08, opened at $11.91.
- Volume was 61.60K shares, 0.9x its 50-day average of 67.18K.
- Price is -12.6% vs its 50-day average ($13.73) and -17.4% vs its 200-day average ($14.51).
- 52-week range $11.83–$20.90; today's close sits at 2% of that range, 42.6% below the 52-week high.
- That makes 8 straight losses.
Oct 7, 2026 — AMRN dips 0.4% to $12.02, a 52-week low, 7 down days in a row
- Closed at $12.02, -0.41% vs the prior close of $12.07. Day range $11.86–$12.05, opened at $12.00.
- Volume was 74.90K shares, 1.1x its 50-day average of 66.99K.
- Price is -12.7% vs its 50-day average ($13.77) and -17.2% vs its 200-day average ($14.52).
- 52-week range $11.83–$20.90; today's close sits at 2% of that range, 42.5% below the 52-week high.
- That makes 7 straight losses.
Oct 6, 2026 — AMRN ends flat (-0.2%) to $12.07, a 52-week low, 6 down days in a row
- Closed at $12.07, -0.17% vs the prior close of $12.09. Day range $11.83–$12.28, opened at $12.09.
- Volume was 75.40K shares, 1.1x its 50-day average of 66.53K.
- Price is -12.6% vs its 50-day average ($13.81) and -16.9% vs its 200-day average ($14.53).
- 52-week range $11.83–$20.90; today's close sits at 3% of that range, 42.2% below the 52-week high.
- That makes 6 straight losses.
Oct 5, 2026 — AMRN dips 2.1% to $12.09, a 52-week low, 5 down days in a row
- Closed at $12.09, -2.11% vs the prior close of $12.35. Day range $12.00–$12.34, opened at $12.29.
- Volume was 79.80K shares, 1.2x its 50-day average of 66.04K.
- Price is -12.7% vs its 50-day average ($13.84) and -16.9% vs its 200-day average ($14.54).
- 52-week range $12.00–$20.90; today's close sits at 1% of that range, 42.2% below the 52-week high.
- That makes 5 straight losses.
Oct 2, 2026 — AMRN dips 2.9% to $12.35, a 52-week low, 4 down days in a row
- Closed at $12.35, -2.91% vs the prior close of $12.72. Day range $12.31–$13.02, opened at $13.00.
- Volume was 100.40K shares, 1.5x its 50-day average of 64.87K.
- Price is -11.0% vs its 50-day average ($13.87) and -15.1% vs its 200-day average ($14.55).
- 52-week range $12.31–$20.90; today's close sits at 0% of that range, 40.9% below the 52-week high.
- That makes 4 straight losses.
AMRN latest news & SEC filings
Every SEC filing by or about AMRN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 27, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 29, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $42.21M (prior year $72.74M) (-42.0% vs Jun 30, 2025)
- Net income: -$7.65M (prior year -$14.14M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.02 (prior year -$0.03) (loss narrowed vs Jun 30, 2025)
Jul 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade AMRN
- Last results release: Jul 29, 2026 (8-K Item 2.02). Previous ones: Apr 29, 2026, Feb 25, 2026, Jan 8, 2026. Based on that rhythm, the next report is likely around Oct 28, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.26% (largest 4.2%).
- Liquidity: about 68.19K shares (≈$771.89K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $11.32 vs a range of $11.25–$20.90 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:20 on Apr 11, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-Q Jul 29, 2026; 8-K Jul 29, 2026; 8-K May 15, 2026.
- Share count: 380.69K shares outstanding (Feb 20, 2013), -99.7% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
AMRN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 11.50 | 11.57 | 11.25 | 11.32 | 113.66K |
| Oct 15, 2026 | 11.57 | 11.85 | 11.56 | 11.57 | 54.40K |
| Oct 14, 2026 | 11.47 | 11.79 | 11.40 | 11.61 | 51.00K |
| Oct 13, 2026 | 11.53 | 11.62 | 11.34 | 11.58 | 102.40K |
| Oct 12, 2026 | 11.93 | 11.93 | 11.39 | 11.53 | 90.00K |
| Oct 9, 2026 | 11.99 | 12.20 | 11.95 | 12.03 | 44.90K |
| Oct 8, 2026 | 11.91 | 12.08 | 11.85 | 11.99 | 61.60K |
| Oct 7, 2026 | 12.00 | 12.05 | 11.86 | 12.02 | 74.90K |
| Oct 6, 2026 | 12.09 | 12.28 | 11.83 | 12.07 | 75.40K |
| Oct 5, 2026 | 12.29 | 12.34 | 12.00 | 12.09 | 79.80K |
| Oct 2, 2026 | 13.00 | 13.02 | 12.31 | 12.35 | 100.40K |
| Oct 1, 2026 | 13.00 | 13.04 | 12.63 | 12.72 | 77.30K |
| Sep 30, 2026 | 13.01 | 13.23 | 12.98 | 13.00 | 62.50K |
| Sep 29, 2026 | 13.24 | 13.28 | 13.04 | 13.14 | 19.80K |
| Sep 28, 2026 | 13.19 | 13.47 | 13.06 | 13.25 | 22.80K |
| Sep 25, 2026 | 13.40 | 13.40 | 13.00 | 13.20 | 127.30K |
| Sep 24, 2026 | 13.58 | 13.63 | 13.40 | 13.43 | 47.90K |
| Sep 23, 2026 | 13.71 | 13.81 | 13.50 | 13.72 | 59.80K |
| Sep 22, 2026 | 13.52 | 13.90 | 13.52 | 13.75 | 59.10K |
| Sep 21, 2026 | 13.63 | 13.80 | 13.38 | 13.48 | 38.80K |
About Amarin Corp Plc\Uk
Amarin Corp Plc\Uk (AMRN) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in DUBLIN 2. State of incorporation: United Kingdom. Fiscal year ends December 31. SEC CIK 897448.
AMRN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Patrice Eadon Bonfiglio | Director | Apr 22, 2026 |
| Paul Cohen | Director | Apr 21, 2026 |
| Keith Horn | Director | Apr 21, 2026 |
| Oliver O'Connor | Director | Apr 21, 2026 |
| Kostas D Odysseas | Director | Apr 21, 2026 |
| Louis Iii Sterling | Director | Apr 21, 2026 |
| Diane E. Sullivan | Director | Apr 21, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Aaron Berg | President and CEO | Jun 30, 2026 |
| Peter L. Fishman | SVP, CFO | Aug 3, 2026 |
| David Paul Keenan | EVP, Chief Operating Officer | Jul 15, 2026 |
| Steven B Ketchum | EVP, Chief Scientific Officer | Jul 15, 2026 |
| Jonathan Provoost | EVP, Chief Legal Officer | Jul 15, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
AMRN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $213.65M | $-38.80M | -0.09 | $6.73M |
| Dec 31, 2024 | $228.61M | $-82.18M | -0.20 | $-31.02M |
| Dec 31, 2023 | $306.91M | $-59.11M | -0.15 | $6.88M |
| Dec 31, 2022 | $369.19M | $-105.80M | -0.26 | $-180.09M |
| Dec 31, 2021 | $583.19M | $7.73M | 0.02 | $-66.54M |
Latest balance sheet: total assets $624.36M, total liabilities $180.75M, cash $143.56M (as of Jun 30, 2026).
AMRN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 29, 2026 | 8-K Item 2.02 (results) | $14.16 |
| Apr 29, 2026 | 8-K Item 2.02 (results) | $14.29 |
| Feb 25, 2026 | 8-K Item 2.02 (results) | $14.05 |
| Jan 8, 2026 | 8-K Item 2.02 (results) | $16.40 |
| Oct 29, 2025 | 8-K Item 2.02 (results) | $16.81 |
| Jul 30, 2025 | 8-K Item 2.02 (results) | $14.97 |
| May 7, 2025 | 8-K Item 2.02 (results) | $10.18 |
| Mar 12, 2025 | 8-K Item 2.02 (results) | $8.00 |
| Oct 30, 2024 | 8-K Item 2.02 (results) | $12.00 |
| Jul 31, 2024 | 8-K Item 2.02 (results) | — |
| May 1, 2024 | 8-K Item 2.02 (results) | — |
| Feb 29, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on AMRN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.